Borowiec, A., A. Właszczuk, E. Olakowska, and J. Lewin-Kowalik. “TXNIP Inhibition in the Treatment of Diabetes. Verapamil As a Novel Therapeutic Modality in Diabetic Patients”. Medicine and Pharmacy Reports, June 2022, doi:10.15386/mpr-2187.